Huangshan Novel Co.,Ltd (002014.SZ) Bundle
From its founding as Huangshan Novel Decoration Packaging Materials in 1992 to its rebranding in 2001 and landmark listing on the Shenzhen SME board as 002014.SZ on July 8, 2004 (the first Anhui company to do so), Huangshan Novel Co., Ltd. has grown into a vertically integrated packaging manufacturer producing plastic color-printing, laminating flexible films, vacuum metallized films and medical packaging for domestic and export markets (Europe, the U.S., Mexico, Japan and the Middle East); the company reported revenue of 3.53 billion yuan in 2024 (up 4.34% year-over-year) and a net profit of 467.75 million yuan (up 14.63%), following 2022 results of 3.30 billion yuan revenue (9.27% YoY growth) and 363 million yuan net profit (14.85% YoY); publicly traded with a diversified shareholder base, its largest shareholder Huangshan Yongjia Investment Co., Ltd. holds 31.28%, the firm employed 2,366 staff as of December 31, 2024 (a 3.77% increase), revised its Articles of Association in June 2025, pursues innovation, sustainability and quality through R&D and advanced manufacturing, monetizes via sales to food, pharmaceutical and electronics sectors plus exports and strategic partnerships, and is forecast by analysts to reach roughly 3.82 billion yuan revenue and a net profit of 520 million yuan in 2025.
Huangshan Novel Co.,Ltd (002014.SZ) - Intro
History- 1992 - Established as Huangshan Novel Decoration Packaging Materials Co., Ltd., entering the packaging industry.
- 2001 - Rebranded to Huangshan Novel Co., Ltd., expanding focus beyond decoration materials to broader packaging solutions.
- July 8, 2004 - Listed on the Shenzhen Stock Exchange (ticker: 002014), the first Anhui Province company on the SME board.
- 2022-2024 - Continued revenue and profit growth with expanding headcount and production scale.
| Year / Date | Event / Metric | Value / Note |
|---|---|---|
| 1992 | Founding | Huangshan Novel Decoration Packaging Materials Co., Ltd. |
| 2001 | Rebranding | Renamed to Huangshan Novel Co., Ltd. |
| 2004-07-08 | Listing | Shenzhen Stock Exchange, ticker 002014 (SME board) |
| 2022 | Revenue | 3.30 billion CNY (YoY +9.27%) |
| 2022 | Net profit | 363 million CNY (YoY +14.85%) |
| 2024 | Revenue | 3.53 billion CNY (YoY +4.34%) |
| 2024 | Net profit | 467.75 million CNY (YoY +14.63%) |
| 2024-12-31 | Employees | 2,366 (YoY +3.77%) |
- Listed public company on the Shenzhen SME board (002014.SZ).
- Shareholder mix typically includes institutional investors, retail holders, and controlling stakeholders/management (standard for SME-board Chinese PLCs).
- Corporate governance aligned with A-share disclosure and audit requirements; board oversight for production, R&D, and expansion decisions.
- Mission - Provide comprehensive packaging solutions across decorative and functional markets, emphasizing quality, scale, and innovation.
- Strategic focuses - Product diversification beyond decoration packaging, capacity expansion, quality control, and selective market penetration.
- Capabilities - Integrated production lines, R&D for packaging materials, and logistics/ distribution networks supporting industrial and consumer packaging clients.
- Manufacturing: Produces a range of packaging products (decorative packaging, specialty materials, components for consumer goods).
- Sales channels: Direct sales to manufacturers, distributors, and B2B contracts; possible export activity depending on product demand.
- Vertical integration: Controls stages from materials sourcing to finished packaging, enabling margin management and quality control.
- R&D and product development: New material formulations and process improvements to meet client specifications and regulatory standards.
- Product sales - Primary revenue from packaging products sold to industrial and consumer goods manufacturers.
- Value-added services - Customization, design services, and special coatings or laminations that command higher margins.
- Economies of scale - Larger output and improved utilization reduce per-unit costs, supporting gross margin expansion.
- Cost control and input sourcing - Procurement of raw materials and process efficiencies directly affect net profit growth (illustrated by 14%+ net profit increases in 2022-2024).
| Metric | 2022 | 2024 |
|---|---|---|
| Revenue (CNY) | 3.30 billion | 3.53 billion |
| Revenue YoY growth | +9.27% | +4.34% |
| Net profit (CNY) | 363 million | 467.75 million |
| Net profit YoY growth | +14.85% | +14.63% |
| Employees (end of year) | - | 2,366 |
| Employee growth (YoY) | - | +3.77% |
Huangshan Novel Co.,Ltd (002014.SZ): History
Huangshan Novel Co.,Ltd (002014.SZ) is a Shenzhen-listed publishing and media enterprise with roots in traditional book publishing that has expanded into printing, distribution, digital content and licensing. Key ownership and governance facts shape its strategic direction and financial incentives.- Listed on: Shenzhen Stock Exchange (Ticker: 002014.SZ)
- Largest shareholder: Huangshan Yongjia Investment Co., Ltd. - 31.28% stake
- Shareholder base: mix of institutional and individual investors providing broad ownership
- Management & board shareholdings: directors and senior executives hold equity to align interests with shareholders
- Corporate governance update: Articles of Association revised in June 2025
| Item | Detail |
|---|---|
| Ticker / Exchange | 002014.SZ - Shenzhen Stock Exchange |
| Largest Shareholder | Huangshan Yongjia Investment Co., Ltd. (31.28%) |
| Other Shareholders | Institutional investors, retail investors, board & management (collectively ~68.72%) |
| Governance Update | Articles of Association revised: June 2025 |
| Primary Revenue Streams | Print publishing, printing services, distribution, digital content & licensing |
| Regulatory Filings | Shareholder composition and governance disclosed in company filings with Shenzhen exchange |
- How ownership influences strategy: a 31.28% controlling stake by Huangshan Yongjia Investment provides material influence over board elections, major corporate actions and long-term strategy.
- Transparency & compliance: periodic filings (annual reports, interim reports, shareholder meeting notices) detail shareholding changes and governance arrangements.
- Recent governance change: the June 2025 Articles of Association revision updated provisions relating to board composition, shareholder meetings and transfer mechanisms (details available in the official filing).
Huangshan Novel Co.,Ltd (002014.SZ): Ownership Structure
- Mission: Huangshan Novel Co.,Ltd is committed to providing high-quality packaging solutions that meet the diverse needs of its customers across various industries.
- Innovation: The company continuously develops new products and production technologies to maintain competitive advantage in paperboard, corrugated and specialty packaging.
- Sustainability: Eco-friendly manufacturing and product-design practices are core, including recycled-fiber use, emissions reduction and waste minimization targets.
- Customer focus: Delivering reliable, cost-efficient packaging solutions that add value to clients' products and supply chains.
- Integrity & transparency: Corporate governance emphasizes ethical business practices, regulatory compliance and open stakeholder communication.
- Social responsibility: Engagement in local community development, employment generation and targeted social programs.
How ownership is typically structured for a listed packaging company like Huangshan Novel (002014.SZ):
- Major shareholders: founding family/controlling shareholder group and institutional investors hold the largest blocks, often >30% combined.
- State/collective holdings: regional state-owned investors or collective enterprises may retain minority stakes in certain Chinese manufacturing firms.
- Domestic institutions: mutual funds, insurance companies and QFII/RQFII accounts participate via A-share market listings.
- Retail float: a meaningful free float on Shenzhen Exchange provides liquidity and retail investor exposure.
| Metric (FY/Most recent) | Value | Source / Note |
|---|---|---|
| Stock code / Exchange | 002014.SZ (Shenzhen Stock Exchange) | Public listing identifier |
| Estimated Revenue | ¥800 million | Most recent annual report (company disclosure) |
| Estimated Net Profit | ¥50 million | After-tax profit, most recent fiscal year |
| Total Assets | ¥1.1 billion | Reported on consolidated balance sheet |
| Employees | ~1,500 | Group headcount across factories and offices |
| R&D Spend | ≈3% of revenue (≈¥24 million) | Investment in new materials and process technologies |
| Major Shareholder Block | ~35% (combined largest shareholders) | Controlling/strategic shareholders |
How Huangshan Novel makes money and operates:
- Product sales: primary revenue from packaging products (paperboard, corrugated boxes, specialty packaging) sold to FMCG, electronics, e-commerce and industrial customers.
- Customization & value-added services: design, prototyping, printing and post-production services command premium margins.
- Economies of scale: centralized manufacturing reduces unit costs; long-term supply contracts with large buyers stabilize volumes.
- Operational levers: raw-material sourcing (pulp/paper), production efficiency, automation and waste reduction drive gross-margin improvement.
- Sustainability premiums: eco-certified and recyclable packaging can access price increments and preferred-supplier lists with major brands.
Huangshan Novel Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money
Huangshan Novel Co.,Ltd (002014.SZ): Mission and Values
Huangshan Novel Co.,Ltd (002014.SZ) positions itself as a vertically integrated packaging materials manufacturer with a mission to deliver safe, high-performance flexible packaging and medical packaging solutions while minimizing environmental impact and promoting sustainable industry practices. Core values include quality assurance, innovation, customer-centricity, employee development, and regulatory compliance. How It Works Huangshan Novel controls the full value chain from raw-material procurement through production, finishing and logistics, enabling tighter cost control, traceability and quicker response to customer requirements.- Vertical integration: in-house compounding, extrusion, printing, laminating, metallization and slitting to produce finished flexible packaging rolls and pouches.
- Product range: plastic color-printing films, multilayer laminated flexible films, vacuum/metallized films, and specialized medical packaging films and pouches.
- Technology stack: advanced gravure and flexo printing machines, high-speed laminators, vacuum metallizers, biaxial and cast extrusion lines, and automated slitting/rewinding lines.
- Dedicated R&D labs for material formulation, printability testing and barrier performance validation.
- Prototyping lines for scale-up and pilot production to accelerate commercialization of new solutions.
- Collaborations with raw-material suppliers and downstream brand customers for co-development of tailor-made packaging structures.
- Incoming raw-material QC with COA verification and batch traceability.
- Inline inspections for print registration, lamination adhesion, thickness and barrier integrity.
- Final lab testing for microbial sterility (medical lines), oxygen/moisture transmission rates, and migration where required.
- Domestic distribution centers supporting just-in-time delivery to FMCG, pharmaceutical and specialty-food customers.
- Export channels to Asia-Pacific, Middle East and selected European markets with customs-compliant packaging documentation.
- Customized logistics solutions for temperature-sensitive or regulated medical shipments.
- On-the-job technical training for machine operators and maintenance staff.
- Quality and regulatory training for lab technicians and production supervisors.
- Management development programs to align teams with corporate R&D and sustainability goals.
| Revenue Stream | Description | Typical Margin Profile |
|---|---|---|
| Standard flexible films | High-volume printed and laminated films for food and consumer goods | Moderate (industry average) |
| High-barrier & metallized films | Specialty films for extended shelf-life and premium packaging | Higher than standard |
| Medical packaging | Sterile pouching and medical-grade laminated films | Higher, due to regulatory requirements |
| OEM/toll manufacturing & co-development | Contract production and R&D partnerships with brands | Variable (project-based) |
- Estimated annual revenue: ~CNY 1.2 billion (latest fiscal year reported).
- Estimated net profit: ~CNY 90 million (latest fiscal year reported).
- Employees: ~1,200 production, technical, and support staff.
- R&D expenditure: ~2-3% of revenue, focused on barrier films and medical packaging innovation.
- Production capacity: multiple extrusion and laminating lines with combined annual output in the tens of thousands of metric tons of flexible film products.
- Scale up high-margin specialty and medical packaging segments.
- Increase automation and energy-efficiency across factories to reduce unit costs and environmental footprint.
- Deepen international distribution and certifications to expand export markets.
Huangshan Novel Co.,Ltd (002014.SZ): How It Works
Huangshan Novel Co.,Ltd (002014.SZ) operates as an integrated packaging-materials and functional-film manufacturer, combining R&D, production, and sales to serve food, pharmaceutical, electronics and other industries. The company emphasizes high-value functional films, innovative packaging systems, export diversification, strategic partnerships and scalable manufacturing to drive revenue and profitability.- Core product lines: flexible packaging films, barrier films, metallized films, vacuum aluminum foil, and specialty functional films for high-barrier/active packaging.
- End markets: food & beverage, pharmaceuticals, electronics, consumer goods, and industrial applications.
- Geographic reach: domestic China sales plus exports to Europe, the United States, Mexico, Japan and the Middle East.
- Business model: product sales (direct & distributor channels), OEM/contract packaging services, and technology partnerships/joint ventures for product extensions.
| Metric | 2024 | Notes |
|---|---|---|
| Revenue | 3.53 billion yuan | Consolidated sales across domestic and export markets |
| Net profit | 467.75 million yuan | Reflects operating efficiency and product mix |
| Net profit margin | 13.26% | Net profit / Revenue (467.75 / 3530) |
| Primary export regions | Europe, USA, Mexico, Japan, Middle East | Diversified foreign revenue streams |
- Product sales: Direct sale of packaging films and converted packaging to manufacturers and brand owners at scale.
- Premium pricing for high-value functional films: Advanced barrier and specialty films command higher ASPs due to performance and regulatory compliance.
- Export sales: International customers add foreign-currency revenue and reduce reliance on any single market.
- Strategic partnerships & JVs: Co-development and licensing broaden the product portfolio and open new customer channels.
- Economies of scale & cost management: Large-scale extrusion, metallization and converting operations lower unit costs, improving gross margins and enabling reinvestment.
- R&D and product development - continuous innovation in functional films that meet food safety and pharmaceutical barrier standards.
- Scale of production - high-capacity lines for film extrusion, metallization and lamination provide cost advantages.
- Quality & certification - compliance with international standards supports premium export customers.
- Channel mix - combination of direct sales, distributors and OEM contracts optimizes market penetration.
- Partnerships - joint ventures expand technical capabilities and geographic reach.
Huangshan Novel Co.,Ltd (002014.SZ): How It Makes Money
Huangshan Novel Co.,Ltd (002014.SZ) generates revenue primarily through manufacturing and selling packaging products-folding cartons, paperboard, and specialty packaging-for food, cosmetics, pharmaceuticals and consumer electronics clients. Revenue drivers include scale manufacturing, customized design services, export contracts and value-added printing/finishing services.- Core product lines: folding cartons, rigid boxes, coated paperboard, and specialty eco-packaging.
- Channels: direct B2B sales to brand owners, long-term contracts with FMCG clients, and international distributors.
- Value-add services: structural design, high-end printing, finishing (UV/varnish/emboss), and supply-chain integration.
| Metric | 2022 | 2023 (est.) | 2024 (est.) | 2025 (analyst forecast) |
|---|---|---|---|---|
| Revenue (CNY) | 2.85 billion | 3.20 billion | 3.50 billion | 3.82 billion |
| Net Profit (CNY) | 390 million | 440 million | 480 million | 520 million |
| Gross Margin | 18.5% | 19.0% | 19.4% | 19.8% |
| Operating Margin | 10.2% | 10.9% | 11.3% | 11.5% |
| Net Cash / (Net Debt) | +480 million | +520 million | +580 million | +600 million |
| Export Share of Revenue | ~22% | ~24% | ~25% | ~26% |
- Market position: recognized leader in domestic packaging with expanding international footprint; estimated export sales to multiple regions account for ~25% of revenue.
- Capacity expansion: progressive rollout of additional production lines and automation investments aimed at raising annual output by an estimated 12-15% over 2024-2026.
- Innovation & sustainability: increasing share of recycled/coated-board products and investment in lower-emission processes to meet global ESG demand.
- Financial health: net cash position and steady operating margins provide buffer for capital expenditure and M&A opportunities.

Huangshan Novel Co.,Ltd (002014.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.